Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis: a randomised, controlled clinical trial

Conclusions
Despite having greater reduction in P. aeruginosa density in participants able to provide sputum samples, participants randomised to placebo with inhaled tobramycin did not experience significantly greater improvements in lung function or other clinical outcomes compared with those randomised to azithromycin with tobramycin.

Source: Thorax - May 17, 2022 Category: Respiratory Medicine Authors: Nichols, D. P., Singh, P. K., Baines, A., Caverly, L. J., Chmiel, J. F., GIbson, R. L., Lascano, J., Morgan, S. J., Retsch-Bogart, G., Saiman, L., Sadeghi, H., Billings, J. L., Heltshe, S. L., Kirby, S., Kong, A., Nick, J. A., Mayer-Hamblett, N., TEACH St Tags: Open access, Thorax Cystic fibrosis Source Type: research